CRNA — Circio Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK1.79bn
- NOK1.80bn
Brief: Targovax Appoints Dr. Erik Digman Wiklund As New CEO
Brief: Targovax Granted European Patent For ONCOS-102 In Combination With Chemotherapy
Brief: Targovax Q2 Oper Loss Narrows To NOK 24.5 Mln
Brief: Targovax Announces Resignation Of Chief Financial Officer
Brief: Targovax Gets Fast Track Designation For ONCOS-102 In Melanoma
Brief: Targovax's Oncos-102 Mesothelioma 24-Month Data Shows Class-Leading Median Overall Survival
Brief: Targovax Oncos-102 Mesothelioma 24-Month Data Shows Class-Leading Median Overall Survival
Brief: Targovax Q1 Operating Loss Narrows To NOK 23.0 Million
Brief: Targovax Granted U.S. Patent
Brief: Targovax: Continued Survival Benefit In Oncos-102 Trial In Mesothelioma
Brief: Targovax Q4 Net Loss Narrows To NOK 26.2 Million
Brief: Targovax Receives Fast-Track Designation For ONCOS-102
Brief: Targovax And Papyrus Therapeutics Enter Research Collaboration
Brief: Targovax: Sotio Stops Collaboration Trial With Dendritic Cell Vaccine DCVAC In Combination With ONCOS-102
Brief: Targovax Extends Term Of IOVaxis's License Option By 3 Months
Brief: Targovax Announces Effects On Non-Injected Lesions In ONCOS-102 Trial In Anti-PD1 Refractory Melanoma Patients
Brief: Targovax: Encouraging Survival Data For Oncos-102 In Mesothelioma
Brief: Targovax Not To Proceed With Subsequent Offering
Brief: Targovax: Contemplated Private Placement